Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study was to investigate the efficacy and safety of Nocardia rubra Cell Wall Skeleton
(NCWS) in the treatment of diabetic foot ulcer wounds. The study was a prospective,
randomized, controlled, multicentre study . The subjects were randomly divided into two
groups: NCWS group and control group（silver ions dressing）, with a total of 116 cases and 58
cases in each group. Patients in the NCWS group received nocardia rubra cell wall skeleton
for external use, in parallel with silver ions dressing treatment. The efficacy and side
effects were observed, with a primary endpoint of 30-days wound healing rate.
Phase:
Phase 4
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Collaborators:
Affiliated Hospital of Jiangnan University Affiliated Hospital of Nantong University Gulou Hospital Affiliated to Medical College of Nanjing University Huai'an First People's Hospital Suzhou Municipal Hospital